Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.

Many diabetic patients continue to have hyperglycaemia on maximal sulphonylurea therapy. Five different therapeutic options, with the prime aim of achieving normal fasting plasma glucose concentrations, have been compared in 15 asymptomatic, sulphonylurea-treated type 2 diabetic patients in a random...

ver descrição completa

Detalhes bibliográficos
Principais autores: Holman, R, Steemson, J, Turner, R
Formato: Journal article
Idioma:English
Publicado em: 1987

Registros relacionados